# OnCo record veramorph (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/veramorph/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "veramorph" ;
  schema:name "VeraMorph"@en ;
  schema:alternateName "VeraMorph, LLC"@en, "VERAMORPH, LLC"@en ;
  schema:description "VeraMorph is developing VER001, a tablet version of fulvestrant, a hormone-blocking breast cancer drug now given as a monthly injection. It is in laboratory testing."@en ;
  schema:url <https://onco.cc/companies/veramorph/>, <https://www.veramorph.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.veramorph.com/>, <https://www.veramorph.com/portfolio>, <https://reporter.nih.gov/project-details/11457452> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:sections <https://onco.cc/fronts/hormonal/> ;
  onco:technologies <https://onco.cc/technologies/oral-serds/>, <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/ver001/> .